Literature DB >> 29131621

Expanding the Armory: Predicting and Tuning Covalent Warhead Reactivity.

Richard Lonsdale1, Jonathan Burgess1, Nicola Colclough1, Nichola L Davies1, Eva M Lenz1, Alexandra L Orton1, Richard A Ward1.   

Abstract

Targeted covalent inhibition is an established approach for increasing the potency and selectivity of potential drug candidates, as well as identifying potent and selective tool compounds for target validation studies. It is evident that identification of reversible recognition elements is essential for selective covalent inhibition, but this must also be achieved with the appropriate level of inherent reactivity of the reactive functionality (or "warhead"). Structural changes that increase or decrease warhead reactivity, guided by methods to predict the effect of those changes, have the potential to tune warhead reactivity and negate issues related to potency and/or toxicity. The half-life to adduct formation with glutathione (GSH t1/2) is a useful assay for measuring the reactivity of cysteine-targeting covalent warheads but is limited to synthesized molecules. In this manuscript we assess the ability of several experimental and computational approaches to predict GSH t1/2 for a range of cysteine targeting warheads, including a novel method based on pKa. Furthermore, matched molecular pairs analysis has been performed against our internal compound collection, revealing structure-activity relationships between a selection of different covalent warheads. These observations and methods of prediction will be valuable in the design of new covalent inhibitors with desired levels of reactivity.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 29131621     DOI: 10.1021/acs.jcim.7b00553

Source DB:  PubMed          Journal:  J Chem Inf Model        ISSN: 1549-9596            Impact factor:   4.956


  25 in total

1.  Ranking Reversible Covalent Drugs: From Free Energy Perturbation to Fragment Docking.

Authors:  Han Zhang; Wenjuan Jiang; Payal Chatterjee; Yun Luo
Journal:  J Chem Inf Model       Date:  2019-02-27       Impact factor: 4.956

Review 2.  Selective and Effective: Current Progress in Computational Structure-Based Drug Discovery of Targeted Covalent Inhibitors.

Authors:  Giulia Bianco; David S Goodsell; Stefano Forli
Journal:  Trends Pharmacol Sci       Date:  2020-11-02       Impact factor: 14.819

3.  Function-Oriented and Modular (+/-)-cis-Pseudoguaianolide Synthesis: Discovery of New Nrf2 Activators and NF-κB Inhibitors.

Authors:  Fabien Emmetiere; Ranjala Ratnayake; Henry A M Schares; Katherine F M Jones; Emily Bevan-Smith; Hendrik Luesch; Daniel A Harki; Alexander J Grenning
Journal:  Chemistry       Date:  2021-02-26       Impact factor: 5.236

4.  Allocolchicinoids bearing a Michael acceptor fragment for possible irreversible binding of tubulin.

Authors:  Ekaterina S Sazanova; Iuliia A Gracheva; Diane Allegro; Pascale Barbier; Sébastien Combes; Elena V Svirshchevskaya; Alexey Yu Fedorov
Journal:  RSC Med Chem       Date:  2020-06-04

5.  New Chemical Biology Tools for the Histamine Receptor Family.

Authors:  Yang Zheng; Gábor Wágner; Niels Hauwert; Xiaoyuan Ma; Henry F Vischer; Rob Leurs
Journal:  Curr Top Behav Neurosci       Date:  2022

6.  Determining Michael Acceptor Reactivity from Kinetic, Mechanistic, and Computational Analysis for the Base-catalyzed Thiol-Michael Reaction.

Authors:  Sijia Huang; Kangmin Kim; Grant M Musgrave; Marcus Sharp; Jasmine Sinha; Jeffrey W Stansbury; Charles B Musgrave; Christopher N Bowman
Journal:  Polym Chem       Date:  2021-05-29       Impact factor: 5.364

7.  Virtual Screening Based on Machine Learning Explores Mangrove Natural Products as KRASG12C Inhibitors.

Authors:  Lianxiang Luo; Tongyu Zheng; Qu Wang; Yingling Liao; Xiaoqi Zheng; Ai Zhong; Zunnan Huang; Hui Luo
Journal:  Pharmaceuticals (Basel)       Date:  2022-05-08

8.  On the intrinsic reactivity of highly potent trypanocidal cruzain inhibitors.

Authors:  Vinicius Bonatto; Pedro Henrique Jatai Batista; Lorenzo Cianni; Daniela De Vita; Daniel G Silva; Rodrigo Cedron; Daiane Y Tezuka; Sérgio de Albuquerque; Carolina Borsoi Moraes; Caio Haddad Franco; Jerônimo Lameira; Andrei Leitão; Carlos A Montanari
Journal:  RSC Med Chem       Date:  2020-09-09

9.  Drugging the undruggable: a computational chemist's view of KRASG12C.

Authors:  Michael S Bodnarchuk; Doyle J Cassar; Jason G Kettle; Graeme Robb; Richard A Ward
Journal:  RSC Med Chem       Date:  2021-03-29

10.  An automatic pipeline for the design of irreversible derivatives identifies a potent SARS-CoV-2 Mpro inhibitor.

Authors:  Daniel Zaidman; Paul Gehrtz; Mihajlo Filep; Daren Fearon; Ronen Gabizon; Alice Douangamath; Jaime Prilusky; Shirly Duberstein; Galit Cohen; C David Owen; Efrat Resnick; Claire Strain-Damerell; Petra Lukacik; Haim Barr; Martin A Walsh; Frank von Delft; Nir London
Journal:  Cell Chem Biol       Date:  2021-06-25       Impact factor: 8.116

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.